Jonathan Monson Boston Scientific Corp (BSX) insider trading activity

Jonathan Monson is SVP, Global Controller and CAO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 37,982 shares of BSX, which is worth approximately $3.39 Million. The most recent transaction as insider was on Feb 18, 2024, when has been sold 258 shares (Common Stock) at a price of $65.82 per share, resulting in proceeds of $16,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38K

0% 3M change

5.88% 12M change

Total Value Held $3.39 Million

Jonathan Monson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2024	SELL Payment of exercise price or tax liability	$16,981 $65.82 p/Share	258 Reduced 0.67%	37,982 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	638 Added 1.64%	38,240 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$26,591 $65.82 p/Share	404 Reduced 1.06%	37,602 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	1,000 Added 2.56%	38,006 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$28,105 $65.82 p/Share	427 Reduced 1.14%	37,006 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	990 Added 2.58%	37,433 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$32,183 $65.95 p/Share	488 Reduced 1.32%	36,443 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	1,057 Added 2.78%	36,931 Common Stock
Aug 02 2023	SELL Payment of exercise price or tax liability	$24,651 $50.62 p/Share	487 Reduced 1.34%	35,874 Common Stock
Aug 02 2023	BUY Exercise of conversion of derivative security	-	1,090 Added 2.91%	36,361 Common Stock
Jul 01 2023	SELL Payment of exercise price or tax liability	$17,633 $54.09 p/Share	326 Reduced 0.92%	35,271 Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	729 Added 2.01%	35,597 Common Stock
Mar 31 2023	SELL Open market or private sale	$250,000 $50.0 p/Share	5,000 Reduced 12.54%	34,868 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	$64,450 $12.89 p/Share	5,000 Added 11.14%	39,868 Common Stock
Mar 01 2023	SELL Open market or private sale	$233,299 $46.66 p/Share	5,000 Reduced 12.54%	34,868 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$64,450 $12.89 p/Share	5,000 Added 11.14%	39,868 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$11,649 $46.23 p/Share	252 Reduced 0.72%	34,868 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	623 Added 1.74%	35,120 Common Stock
Feb 18 2023	SELL Payment of exercise price or tax liability	$11,821 $46.54 p/Share	254 Reduced 0.73%	34,497 Common Stock
Feb 18 2023	BUY Exercise of conversion of derivative security	-	637 Added 1.8%	34,751 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$19,593 $46.54 p/Share	421 Reduced 1.22%	34,114 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	1,000 Added 2.81%	34,535 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$21,194 $46.48 p/Share	456 Reduced 1.34%	33,535 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	990 Added 2.83%	33,991 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$16,078 $47.29 p/Share	340 Reduced 1.02%	33,001 Common Stock

Jonathan Monson

SVP, Global Controller and CAO

Marlborough, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BSX shares.

Notify only if

Value

Insider Trading

Get notified when an Boston Scientific Corp insider buys or sells BSX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BOSTON SCIENTIFIC CORP

Track Activities on BSX

Account